| 1 |
35159151 | Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses. | 2022 Jan 20 |
1 |
| 2 |
35470665 | Synthesis and Immunological Evaluation of Pentamannose-Based HIV-1 Vaccine Candidates. | 2022 May 18 |
2 |
| 3 |
33177194 | Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses. | 2021 Jan 13 |
1 |
| 4 |
33529763 | High level stable expression of recombinant HIV gp120 in glutamine synthetase gene deficient HEK293T cells. | 2021 May |
1 |
| 5 |
34327564 | Identification of N-glycans with GalNAc-containing antennae from recombinant HIV trimers by ion mobility and negative ion fragmentation. | 2021 Dec |
1 |
| 6 |
34451811 | Red Algal Sulfated Galactan Binds and Protects Neural Cells from HIV-1 gp120 and Tat. | 2021 Jul 23 |
1 |
| 7 |
34679128 | Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens. | 2021 Oct |
1 |
| 8 |
34745128 | Sequential Analysis of the N/O-Glycosylation of Heavily Glycosylated HIV-1 gp120 Using EThcD-sceHCD-MS/MS. | 2021 |
1 |
| 9 |
32371950 | Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies. | 2020 May 5 |
1 |
| 10 |
32866207 | Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates. | 2020 Aug |
1 |
| 11 |
33057580 | Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate. | 2020 Nov 13 |
2 |
| 12 |
33361123 | Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection. | 2020 Dec 23 |
1 |
| 13 |
29306566 | Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity. | 2018 Mar |
1 |
| 14 |
29343613 | Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus. | 2018 Mar 9 |
1 |
| 15 |
29474444 | Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. | 2018 Feb |
1 |
| 16 |
29593217 | Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope. | 2018 Mar 28 |
1 |
| 17 |
29689099 | Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies. | 2018 |
2 |
| 18 |
29746590 | Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins. | 2018 May |
1 |
| 19 |
30021899 | Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques. | 2018 Oct 1 |
1 |
| 20 |
30115684 | Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake. | 2018 Sep 28 |
9 |
| 21 |
27908641 | Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1. | 2017 Apr 7 |
1 |
| 22 |
27984693 | Global N-Glycan Site Occupancy of HIV-1 gp120 by Metabolic Engineering and High-Resolution Intact Mass Spectrometry. | 2017 Feb 17 |
2 |
| 23 |
28202756 | Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers. | 2017 May 1 |
1 |
| 24 |
28314374 | HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies. | 2017 Aug |
1 |
| 25 |
28446609 | Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity. | 2017 Jun 16 |
1 |
| 26 |
28632942 | The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation. | 2017 Dec |
49 |
| 27 |
28667249 | Conformational Heterogeneity of the HIV Envelope Glycan Shield. | 2017 Jun 30 |
1 |
| 28 |
28947103 | Interrogation of side chain biases for oligomannose recognition by antibody 2G12 via structure-guided phage display libraries. | 2017 Oct 15 |
1 |
| 29 |
27001729 | Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies. | 2016 Apr |
1 |
| 30 |
27067056 | Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor. | 2016 Apr 19 |
1 |
| 31 |
27275831 | A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity. | 2016 Jun 6 |
1 |
| 32 |
27581986 | Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site. | 2016 Nov 15 |
2 |
| 33 |
27604319 | Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding. | 2016 Sep 8 |
1 |
| 34 |
27669574 | Binding Site Geometry and Subdomain Valency Control Effects of Neutralizing Lectins on HIV-1 Viral Particles. | 2016 Nov 11 |
1 |
| 35 |
27707925 | HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual. | 2016 Dec 15 |
1 |
| 36 |
27851829 | Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth. | 2016 Nov |
2 |
| 37 |
25546301 | Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262. | 2015 Mar |
2 |
| 38 |
25878100 | Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance. | 2015 Jul |
1 |
| 39 |
26019370 | Synthesis of a polymerizable, bivalent glycan mimetic of the HIV envelope spike gp120. | 2015 Jun 3 |
2 |
| 40 |
26085151 | Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope. | 2015 Sep |
1 |
| 41 |
26086186 | Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein. | 2015 Nov |
2 |
| 42 |
26105115 | Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies. | 2015 Jun 24 |
1 |
| 43 |
26457433 | Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer. | 2015 Oct |
2 |
| 44 |
26540494 | Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers. | 2015 Dec 1 |
1 |
| 45 |
24645849 | Directed evolution of multivalent glycopeptides tightly recognized by HIV antibody 2G12. | 2014 Apr 9 |
1 |
| 46 |
24767986 | Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. | 2014 May 8 |
1 |
| 47 |
24828077 | Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. | 2014 May 14 |
1 |
| 48 |
24884609 | Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4. | 2014 Jul 3 |
1 |
| 49 |
24965454 | Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy. | 2014 Sep 1 |
2 |
| 50 |
24967714 | Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity. | 2014 |
4 |